Capricor Therapeutics CAPR Q2 2025 earnings
Reported August 11, 2025 · After market close
Revenue estimate$480.0K
EPS estimate-$0.48
Next report
Aug 11, 2026 (In 4 weeks)Revenue estimate$2.1M
EPS estimate-$0.58
Financials
Q2 2025Valuation & ratios
Versus estimates
Revenue
Diluted EPS
Ask the moment Capricor Therapeutics reports.
Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.
Connect your AI
Claude
Questions, answered.
- When did Capricor Therapeutics report Q2 2025 earnings?
- Capricor Therapeutics (CAPR) reported Q2 2025 earnings on August 11, 2025 after market close.
- What were Capricor Therapeutics's Q2 2025 revenue and EPS?
- Capricor Therapeutics reported revenue of - and diluted EPS of $-0.57 for Q2 2025.
- Did Capricor Therapeutics beat estimates in Q2 2025?
- Revenue missed the consensus estimate of $480.0K by $480.0K. EPS missed the consensus estimate of $-0.48 by $0.09.
- How did Capricor Therapeutics's Q2 2025 results compare year-over-year?
- Compared to the same quarter a year prior, revenue declined 100.0% from $4.0M a year earlier and diluted EPS declined 62.9% from $-0.35.
- Where can I find Capricor Therapeutics's Q2 2025 SEC filings?
- You can read the 10-Q periodic report (0001558370-25-011084) directly on SEC EDGAR. The filing index links above go to sec.gov.